Shire Nabs Advanced BioHealing Just Prior To Planned IPO
This article was originally published in The Gray Sheet
Executive Summary
Just before its planned debut on the New York Stock Exchange, wound healing device maker Advanced BioHealing Inc. instead agreed to a $750 million buyout offer May 17 from drug maker Shire PLC, which has a history of using acquisitions to jump quickly into new lines of business.